BRAINSTORM CELL THERAPEUTICS INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $51.3M
Liabilities Breakdown FY2020
Total Liabilities: $15.8M
Asset Breakdown
Total Assets: $51.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $37.8M | 73.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.1M | 2.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $12.3M | 24.0% |
Liabilities Breakdown
Total Liabilities: $15.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.4M | 34.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $10.4M | 65.7% |